The VA will cover private-sector primary, mental health and extended care for veterans whose average drive time to the nearest VA health care facility is longer than 30 minutes, along with specialized care for veterans who live an hour’s drive or more from the nearest VA provider. Private-sector providers must be in a pre-approved network, and veterans may be charged a copay for some care. Government Executive
MLN Matters published an article (SE 19003) on January 17, 2019 clarifying the documentation required by CMS as proof of delivery of DMEPOS products to Medicare beneficiaries effective 11/20/2017; the information can be found in the Medicare Program Integrity Manual Chapter 4 Section 26. As a reminder, Medicare Suppliers are required to retain documentation of delivery for 7 years from the starting date of service.
Maintaining proof of delivery is required as part of record keeping for CHAP accredited organizations (Ref: CHAP standards HMEII.2c and HMEII.8a).
HMEII.2c Delivery of equipment and supplies to clients includes, at a minimum: 13) Record keeping including documentation of the delivery, setup and the client’s receipt of equipment
HMEII.8a Records of equipment, services and care provided include: 4) Date product was delivered and service provided.
Refer also to the DMEPOS Supplier Standards (CFR 424.57): (12) Must be responsible for the delivery of Medicare covered items to beneficiaries and maintain proof of delivery. (The supplier must document that it or another qualified party has at an appropriate time, provided beneficiaries with necessary information and instructions on how to use Medicare-covered items safely and effectively);
Recommendations for meeting compliance:
- Verify organizational policy and procedures describe required documentation for delivery of products and services, as well as required timeframes for retention of records/documentation.
- Train applicable staff on documentation required to be obtained with delivery as well as what information should be retained in the client record.
- Review client records for evidence of the proof of delivery. For Medicar Beneficiaries ensure this information is retained on file for 7 years.
The US Food and Drug Administration is warning of a shortage of a class of drugs used by millions to treat high blood pressure. According to FDA Commissioner Dr. Scott Gottlieb and FDA director of drug evaluation and research Dr. Janet Woodcock, drugs that contain valsartan (known as ARBs, or angiotensin II receptor blockers) “are in shortage, and we know that other types of products may fall into shortage soon.”
The FDA said its ongoing investigation had determined the impurities were generated in the manufacturing process and could have resulted “from the reuse of materials, such as solvents.”
Full article is below:
Most of us have heard about 2016 CDC Opioid Guideline, which is supposed to be a voluntary guideline for primary care physicians treating non-cancer pain.
What has happened? In the span of two years the guideline has seemingly become law. Countless pain patients have made the trek to their doctor dreading the thought that their lifeline — opioid pain medication – will be reduced or even discontinued.
The limited availability of drug products has been a national concern for many years. Specialty medications have some unique concerns when considering patient access during times of product unavailability, but there are several reasons why a specialty drug may not be available for patients in need of treatment. More on this, click here: https://www.specialtypharmacytimes.com/news/access-barriers-to-specialty-medications
The Food and Drug Administration announced an overhaul of the decades-old system that these devices have to go through to be approved for use. For more information, click here: https://www.healthlawadvisor.com/2018/12/11/fda-to-overhaul-medical-device-approval-process/